Abstract
Ocular toxoplasmosis in non immuno-deficients can take 3 major aspects:
-
1)
Pseudo-acquired (congenital) forms in teenagers and young adults;
-
2)
Congenital forms in the newborn;
-
3)
Acquired toxoplasmosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bloch-Michel E, Sibillat M, Cerqueti PM, Timsit JC. Ocular toxoplasmosis in France. World Uveitis Symposium Guaruja, Brasil. Sao Paolo, March 16th–19th, 1988 (in press).
Bloch-Michel E, Campinchi R, Schmitt A, Goichot E, Niessen F. Le prix d'une toxoplasmose oculaire. Bull Soc Ophtalmol Fr, 1981; 81: 739–740.
Timsit JC, Bloch-Michel E. Efficacité de la chimiothérapie spécifique dans la prévention des récidives des choriorétinites toxoplasmiques dans les quatre années qui suivent le traitement. J Fr Ophtalmol, 1987; 10: 15–23.
Couvreur J, Bloch-Michel E. Toxoplasmose oculaire: traitement préventif et curatif. Med Hyg 1985; 43: 2216–2220.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bloch-Michel, E. Ocular toxoplasmosis — Clinical aspect. Int Ophthalmol 14, 353–357 (1990). https://doi.org/10.1007/BF00163556
Issue Date:
DOI: https://doi.org/10.1007/BF00163556